- Report
- July 2025
- 350 Pages
Global
From €4494EUR$4,949USD£3,829GBP
- Report
- July 2025
- 350 Pages
Global
From €4494EUR$4,949USD£3,829GBP
- Report
- April 2026
- 149 Pages
Global
From €2724EUR$2,999USD£2,320GBP
€3632EUR$3,999USD£3,094GBP
- Report
- April 2026
- 135 Pages
Global
From €2724EUR$2,999USD£2,320GBP
€3632EUR$3,999USD£3,094GBP
- Report
- April 2026
- 143 Pages
Global
From €2724EUR$2,999USD£2,320GBP
€3632EUR$3,999USD£3,094GBP
- Report
- January 2026
- 120 Pages
Global
From €4314EUR$4,750USD£3,675GBP
- Report
- April 2026
- 140 Pages
Global
From €3587EUR$3,950USD£3,056GBP
- Report
- October 2025
- 160 Pages
Global
From €2870EUR$3,160USD£2,445GBP
€3587EUR$3,950USD£3,056GBP
- Report
- October 2025
- 160 Pages
Global
From €2870EUR$3,160USD£2,445GBP
€3587EUR$3,950USD£3,056GBP
- Report
- October 2025
- 160 Pages
Global
From €2870EUR$3,160USD£2,445GBP
€3587EUR$3,950USD£3,056GBP
- Report
- November 2025
- 150 Pages
Global
From €4405EUR$4,850USD£3,753GBP
- Report
- November 2025
- 150 Pages
Global
From €4405EUR$4,850USD£3,753GBP
- Report
- October 2025
- 150 Pages
Global
From €4405EUR$4,850USD£3,753GBP
- Report
- January 2025
- 100 Pages
Global
From €5404EUR$5,950USD£4,604GBP
- Report
- December 2024
- 100 Pages
Global
From €5404EUR$5,950USD£4,604GBP
- Report
- July 2024
- 120 Pages
Global
From €5404EUR$5,950USD£4,604GBP
- Report
- July 2025
- 200 Pages
Australia
From €2261EUR$2,490USD£1,927GBP
- Report
- July 2025
Global
From €4450EUR$4,900USD£3,791GBP
- Report
- April 2025
Global
From €4450EUR$4,900USD£3,791GBP
- Report
- December 2022
- 120 Pages
Global
From €4087EUR$4,500USD£3,482GBP

Proton Pump Inhibitors (PPIs) are a class of drugs used to treat Gastrointestinal (GI) disorders. They work by reducing the amount of acid produced in the stomach, which helps to relieve symptoms of acid reflux, heartburn, and other GI conditions. PPIs are available in both prescription and over-the-counter forms, and are often used in combination with other medications to treat more severe GI conditions. Common side effects of PPIs include headache, nausea, and diarrhea.
PPIs are among the most widely prescribed drugs in the world, and are used to treat a variety of GI conditions. They are often used as a first-line treatment for acid reflux and other GI disorders, and are also used to prevent and treat ulcers.
Some of the major companies in the PPI market include AstraZeneca, Pfizer, Takeda, and GlaxoSmithKline. These companies produce a variety of PPIs, including omeprazole, lansoprazole, and pantoprazole. Show Less Read more